Urology · Torrance, CA
NPI
1164666228
Since 2009
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
20911 Earl St, Suite 140
Torrance, CA, 90503
Phone (310) 542-0199
Groups this clinician bills Medicare through
Medicare paid, 2024
$670K
35,031 services
Medicare patients, 2024
1,656
Average age 76
Drug cost, 2024
$442K
2,373 prescriptions
Company payments, 2025
$1,860
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Shelby N Morrisroe was code J0585 (injection, onabotulinumtoxina, 1 unit), 9,300 times for 59 patients. In total Shelby N Morrisroe billed 35,031 services in 101 codes, and Medicare paid $670K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-04-04.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0585 Injection, onabotulinumtoxina, 1 unit | Office | 9,300 | 59 | $4.98 | $46K |
| J1071 Injection, testosterone cypionate, 1 mg | Office | 8,000 | 11 | $0.02 | $146 |
| 81003 Clinical Chemistry | Office | 1,385 | 953 | $2.19 | $3,032 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 1,287 | 1,066 | $14.53 | $19K |
| 99214 Office E&M - Established | Office | 1,070 | 884 | $112.24 | $120K |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 1,040 | 276 | $44.54 | $46K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 962 | 322 | $56.09 | $54K |
| 51798 Ultrasound - Nonspecific | Office | 840 | 720 | $10.84 | $9,106 |
| 99489 Chronic, Principal, and Transitional Care Management | Office | 629 | 124 | $67.64 | $43K |
| 99213 Office E&M - Established | Office | 375 | 340 | $79.68 | $30K |
| 76770 Ultrasound - Abdomen and Pelvis | Office | 300 | 249 | $92.16 | $28K |
| 64566 Musculoskeletal | Office | 234 | 45 | $110.33 | $26K |
| 99487 Chronic, Principal, and Transitional Care Management | Office | 231 | 124 | $124.54 | $29K |
| 99459 Office/Outpatient Services | Office | 208 | 177 | $22.32 | $4,642 |
| 99211 Office E&M - Established | Office | 181 | 129 | $21.57 | $3,903 |
By year: 2022 $583K for 18,109 services; 2023 $738K for 23,207 services; 2024 $670K for 35,031 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 1,385 | 953 | $2.19 | $3,032 |
Medicare prescription drug claims, 2024
In 2024, the drug Shelby N Morrisroe prescribed most often to Medicare patients was Ciprofloxacin Hcl, with 291 prescriptions and refills. In total Shelby N Morrisroe wrote 2,373 Medicare prescriptions that cost $442K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ciprofloxacin Hcl Generic | 291 | 293 | 197 | $960 |
| Estradiol Generic | 236 | 660 | 151 | $19K |
| Cefdinir Generic | 199 | 199 | 139 | $2,404 |
| Methenamine Hippurate Generic | 193 | 494 | 69 | $24K |
| Myrbetriq Mirabegron | 179 | 345 | 61 | $155K |
| Gemtesa Vibegron | 167 | 354 | 59 | $163K |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 157 | 179 | 92 | $1,953 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 106 | 106 | 79 | $219 |
| Tamsulosin Hcl Generic | 97 | 237 | 31 | $1,740 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 87 | 197 | 38 | $1,671 |
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | 84 | 84 | 57 | $346 |
| Trospium Chloride Er Trospium Chloride | 66 | 130 | 26 | $14K |
| Cephalexin Generic | 60 | 108 | 33 | $397 |
| Fosfomycin Tromethamine Generic | 42 | 46 | 25 | $5,534 |
| Desmopressin Acetate Generic | 38 | 58 | 13 | $620 |
Brand drugs: 426 claims; generic drugs: 1,935 claims; opioid claims: 29.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Shelby N Morrisroe $1,860 ($1,860 in general payments such as food, travel and fees) from 21 companies. The largest payer was Medtronic, Inc. with $389.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 5 | $389 |
| Teleflex LLC TFX | 2 | $386 |
| Abbvie Inc. ABBV | 11 | $261 |
| Dendreon Pharmaceuticals LLC | 5 | $150 |
| Janssen Biotech, Inc. JNJ | 3 | $80.24 |
| Sumitomo Pharma America, Inc. 4506.T | 3 | $72.5 |
| Astellas Pharma US Inc 4503.T | 1 | $68 |
| Boston Scientific Corporation BSX | 2 | $65.61 |
| Edap Technomed Inc | 1 | $45.93 |
| Immunitybio, Inc. IBRX | 2 | $45.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.